eFFECTOR Therapeutics, Inc.

EFTRDelisted Jul 19, 2024

Industry: Pharmaceutical Preparations
SEC CIK: 0001828522

SEC filings (opens in a new tab)

eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of EFTR: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Q4 2022	Change
Holders	27	30	+3
Shares	24.0M	24.3M	+369.3K (+1.5%)
Value	$13.7M	$10.4M	−$3.24M (−23.7%)

New holders (4)

Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to EFTR in Q4 2022
Institution	Shares	Value	% of portfolio
CI Private Wealth, LLC	275,442	$117.8K	0.00%
Intelligence Driven Advisers, LLC	48,768	$24.4K	0.00%
Susquehanna International Group, LLP	33,621	$14.4K	0.00%
Bank of America Corp	48	$20	0.00%

Sold out (1)

Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of EFTR in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Two Sigma Securities, LLC	16,201	$9.00K